https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2013-04-12 17:22:322019-02-12 17:22:47Science kürt Immuntherapie gegen Krebs 2013 zum "Breakthrough of the Year"
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002013-02-01 / BioDrugs 2013 Feb;27(1):35-53https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2013-02-01 / BioDrugs 2013 Feb;27(1):35-532013-02-01 00:00:002021-11-15 16:56:59Bispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002012-04-22 / Cancer Immunol. Immunother. 2012 Nov;61(11):2033-44https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2012-04-22 / Cancer Immunol. Immunother. 2012 Nov;61(11):2033-442012-04-22 00:00:002021-11-15 14:43:58Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2012-01-24 17:24:202019-02-12 17:25:16TV-Beitrag-National Institutes of Health: Will Dendritic Cell Subsets help us address the challenges of Cancer, Autoimmunity and Viral Diseases?
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002011-11-16 / Int. J. Oncol. 2012 Mar;40(3):840-50https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2011-11-16 / Int. J. Oncol. 2012 Mar;40(3):840-502011-11-16 00:00:002021-11-15 16:57:44Newcastle disease virus induces pro-inflammatory conditions and type I interferon for counter-acting Treg activity
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002011-10-04 / Int. J. Oncol. 2012 Jan;40(1):287-98https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2011-10-04 / Int. J. Oncol. 2012 Jan;40(1):287-982011-10-04 00:00:002021-11-15 16:58:12Importance of retinoic acid-inducible gene I and of receptor for type I interferon for cellular resistance to infection by Newcastle disease virus
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2011-09-01 17:28:532019-02-12 17:32:01Nobelpreis für Medizin 2011 für die Entdeckung grundlegender immunologischer Mechanismen
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg00IOZKhttps://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svgIOZK2011-06-28 17:30:112019-02-12 17:30:56Artikel in der WirtschaftsWoche: "Impfung gegen Krebs"
Oncolytic Newcastle Disease Virus as Cutting Edge between Tumor and Host
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2013-07-02 / Biology (Basel) 2013 Jul;2(3):936-75Science kürt Immuntherapie gegen Krebs 2013 zum „Breakthrough of the Year“
/in Externe Meldungen /von IOZKBispecific antibodies and trispecific immunocytokines for targeting the immune system against cancer: preparing for the future
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2013-02-01 / BioDrugs 2013 Feb;27(1):35-53Integration of autologous dendritic cell-based immunotherapy in the standard of care treatment for patients with newly diagnosed glioblastoma: results of the HGG-2006 phase I/II trial
/in Dendritic Cells, Glioblastoma, International Publications, IOZK Veröffentlichungen /von 2012-04-22 / Cancer Immunol. Immunother. 2012 Nov;61(11):2033-44TV-Beitrag-National Institutes of Health: Will Dendritic Cell Subsets help us address the challenges of Cancer, Autoimmunity and Viral Diseases?
/in Externe Meldungen /von IOZKAnalysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2012-01-01 / Methods Mol. Biol. 2012;797:177-204Newcastle disease virus induces pro-inflammatory conditions and type I interferon for counter-acting Treg activity
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2011-11-16 / Int. J. Oncol. 2012 Mar;40(3):840-50Importance of retinoic acid-inducible gene I and of receptor for type I interferon for cellular resistance to infection by Newcastle disease virus
/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2011-10-04 / Int. J. Oncol. 2012 Jan;40(1):287-98Nobelpreis für Medizin 2011 für die Entdeckung grundlegender immunologischer Mechanismen
/in Externe Meldungen, IOZK Meldungen /von IOZKArtikel in der WirtschaftsWoche: „Impfung gegen Krebs“
/in Externe Meldungen /von IOZK